| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |